Aarogya Setu 2.0 is no longer just a COVID-19 app. The Centre has launched a revamped version of the platform with several new features that bring PM-JAY Wallet, Digital Health Records, and other healthcare services under one roof.
The global diabetes clinical trials market is on a steady upward trajectory, projected to grow from USD 5.45 billion in 2026 to USD 10.02 billion by 2034, at a CAGR of 7.9 percent, according to a comprehensive new industry analysis.
.jpg)
A new rule comes into line for expanding the residual shell life of imported drugs in India,amid the wastage of medicines and the capital loss in operation and supply chain management
In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Nilesh Pendse, Director – Vaccines, Pfizer India, discusses the evolving narrative around adult immunization in India. He highlights the importance of awareness, p
India’s Blood Standards Could Transform Patient Safety as India becomes the first country in the world to introduce exclusive standards for blood and blood components under the Indian Pharmacopoeia 2026.
Translational Research could be the key to unlocking the next phase of growth for India's pharmaceutical sector, according to a new white paper that highlights major gaps in the country's innovation ecosystem.
Future FTAs in the Indian pharma industry may look different as India pushes for a stronger pharmaceutical agenda in its trade negotiations.
Biotech innovation accelerates as Parexel launches its incubator, connecting early-stage therapeutics firms with clinical and regulatory expertise to bridge development gaps.
India has crossed a significant milestone in its healthcare journey, with organ donation pledges surpassing the 5 lakh mark.
Himachal Pradesh invests Rs 150 crore in diagnostics as the state government moves to strengthen healthcare infrastructure across the state.
, CDSCO.jpg)